Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
PeptidesSS-31 (Elamipretide) for Metabolic Health: Glucose Insights 2026
SS-31 (Elamipretide) is gaining traction for its impact on mitochondrial function. This article unpacks its emerging role in managing glucose and metabolic health.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers: Insights for 2026
This comprehensive analysis delves into SS-31 (Elamipretide)'s potential to influence critical longevity biomarkers, offering a nuanced perspective on its evidence base as of 2026.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers in 2026
SS-31 (Elamipretide) is often touted for its mitochondrial benefits. We scrutinise its influence on crucial longevity biomarkers, separating robust evidence from early signals.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers: Insights for 2026
SS-31 (Elamipretide) is a peptide targeting mitochondrial health. We dissect its influence on crucial longevity biomarkers, evaluating current evidence and future prospects for healthspan extension.
PeptidesSS-31 (Elamipretide) in 2026: Latest Clinical
A deep dive into SS-31 (Elamipretide)'s most recent clinical findings, focusing on 2025-2026 data and its implications for longevity and healthspan.
PeptidesSS-31 (Elamipretide): Latest Evidence and 2026
Explore the cutting-edge science behind SS-31 (Elamipretide), with a focus on breakthroughs from 2025-2026 and its potential in healthy ageing.
PeptidesSS-31 (Elamipretide) in 2026: Unpacking the
SS-31 (Elamipretide) continues to garner attention for its mitochondrial-targeting properties. We delve into the newest clinical data and revised insights for 2026.
PeptidesSS-31 (Elamipretide) Insights: Latest Evidence
Discover the latest clinical findings for SS-31 (Elamipretide) in 2025-2026, focusing on mitochondrial health and its implications for longevity.
PeptidesSS-31 (Elamipretide) Latest Evidence 2026: A
This updated review focuses on the latest 2025-2026 evidence for SS-31 (Elamipretide), dissecting new clinical trials and their implications for longevity and mitochondrial health.
PeptidesSS-31 Dosing & Protocol Optimisation for
Demystifying SS-31 dosing is crucial for maximising its mitochondrial benefits. We break down protocols for longevity, performance, and recovery, informed by the latest research.
PeptidesOptimising SS-31 (Elamipretide) Dosing for
Understanding the nuanced dosing and protocol for SS-31 (Elamipretide) is paramount for maximising its mitochondrial-targeted benefits, from enhanced recovery to improved healthspan.
PeptidesSS-31 (Elamipretide) for Women: Optimising
SS-31 (Elamipretide) holds promise for optimising female healthspan by targeting mitochondrial dysfunction, particularly relevant through hormonal shifts and menopause.
PeptidesSS-31 (Elamipretide) After 50: Optimising
For those over 50, SS-31 (Elamipretide) offers a targeted approach to combating age-related mitochondrial decline, influencing sarcopenia, cognitive function, and overall vitality.
PeptidesSS-31 Stacks for Longevity in 2026: Optimal
SS-31, a potent mitochondrial peptide, shines brightest when combined thoughtfully. This guide explores optimal stacking strategies for enhanced longevity.
PeptidesSS-31 (Elamipretide) Safety & Side Effects
A deep dive into the safety and side effect profile of SS-31 (Elamipretide), including potential drug interactions, contraindications, and monitoring best practices.
PeptidesSS-31 (Elamipretide) Side Effects & Safety
A deep dive into the safety profile of SS-31 (Elamipretide), examining known side effects, potential interactions, and critical considerations for its use in 2026.
PeptidesSS-31 (Elamipretide) for Sleep in 2026: An
SS-31 (Elamipretide), a mitochondrial-targeting peptide, is gaining attention for its potential impact on sleep quality and circadian rhythm regulation.
PeptidesSS-31 (Elamipretide) UK Availability & Cost
Unraveling the complexities of SS-31 (Elamipretide) in the UK, this guide covers legal standing, expected pricing, and how to source it safely and effectively.
PeptidesSS-31 (Elamipretide) for Cognition in 2026: A
SS-31 (Elamipretide) is gaining attention for its cognitive benefits, primarily through mitochondrial support. This article examines its mechanisms and clinical data.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.